Effect of platelet-rich fibrin on cell proliferation, migration, differentiation, inflammation, and osteoclastogenesis: a systematic review of in vitro studies

Abstract

Objective

To systematically assess the effects of platelet-rich fibrin (PRF) on in vitro cellular behavior.

Methods

A systematic electronic search using MEDLINE database was performed. In vitro studies using PRF were considered and articles published up to June 31, 2018 were screened. Eligible studies were selected based on the use of human PRF.

Results

In total, 1746 titles were identified with the search terms, from these 37 met the inclusion criteria and were chosen for data extraction. In addition, 16 new studies, mainly published in 2019, were also included in the analysis resulting in 53 studies. No meta-analysis could be performed due to the heterogeneity of study designs. Included studies show that PRF enhances proliferation, migration, adhesion, and osteogenic differentiation on a variety of cell types along with cell signaling activation. Furthermore, PRF reduces inflammation, suppresses osteoclastogenesis, and increases the expression of various growth factors in mesenchymal cells.

Summary and conclusions

Despite some notable differences of the studies, the overall findings suggest a positive effect of PRF on cell proliferation, migration, adhesion, differentiation, and inflammation pointing towards a therapeutic potential in regenerative dentistry.

Clinical relevance

PRF serves as a reservoir of bioactive molecules to support wound healing and bone regeneration. Although the cellular mechanisms by which PRF supports the clinical outcomes remain unclear, in vitro research provides possible explanations. This systematic review aims to provide an update of the existing research on how PRF affects basic physiological processes in vitro. The overall findings suggest that PRF induces cell proliferation, migration, adhesion, and differentiation along with possessing anti-inflammatory properties further supporting its therapeutic potential in wound healing and bone regeneration.

Introduction

Platelet-rich fibrin (PRF) is becoming an attractive and widely-used approach in regenerative dentistry. PRF is a platelet-rich plasma that undergoes natural coagulation after being separated from the red thrombus by centrifugation [1]. The evolution of PRF started with the introduction of L-PRF based on a high-speed protocol (~ 700 g for 12 min) [1]. Later on, A-PRF (~ 200 g for 8 min) and injectable PRF (~ 60 g for 3 min) with lower g-forces and centrifugation times were introduced with the overall aim to increase the number of platelets and leucocytes [2]. For this aim, the use of centrifuges with swing-out rotors has also been recommended [2]. Obviously PRF is an umbrella term that comprises various preparations and protocols, therefore a standardization of relative centrifugal forces (RCF) [3] has been suggested. Nonetheless, most of the clinical data derive from the classical L-PRF protocol [1].

Recent systematic reviews dealt with the clinical application of PRF in periodontal defects, periodontal plastic surgery [4], sinus floor elevation, alveolar ridge preservation, or implant therapy [5]. For example, PRF preserves the alveolar ridge after tooth extraction [6], enhances osseointegration in the early phase [7, 8] and can increase the width of keratinized mucosa around implants [9]. Even though emerging evidence indicates that local application of PRF can support the outcomes of the above-mentioned clinical indications, the underlying cellular mechanisms remain unclear. Based on the assumption that PRF supports the conserved cellular mechanisms of wound healing and bone regeneration, it can, therefore, be assumed that PRF drives the cellular responses also under in vitro conditions.

In vitro bioassays can confirm the impact of PRF on standard cellular responses such as proliferation, migration, and differentiation, all of which may predict a possible clinical efficacy. However, care should be taken when interpreting the observations, as the early hematoma that usually forms in defect sites is not represented in the in vitro assays [10]. Readers of this review should also be aware that some of the observations reported for PRF have already been shown for plasma-free leucocyte-depleted activated platelets [11–13] based on the compelling in vitro evidence gained from platelet-rich plasma [14, 15].

The cellular responses to PRF were summarized in a systematic review integrating seven in vitro studies [16]. However, given the increasing number of in vitro studies, not limited to dentistry, a revised view on today's in vitro research on PRF seems justified. This systematic review aims to provide an update of the existing research on how PRF affects basic physiological processes in vitro.

Material and methods

Protocol development and eligibility criteria

A protocol including all aspects of a systematic review methodology was developed prior to starting the review. This included definition of the focused question, a defined search strategy, study inclusion criteria, determination of outcome measures, screening methods, data extraction, and analysis and data synthesis.

Defining the focused question

The following focused question was defined: “what is the effect of PRF on cell behavior in in vitro studies?”

Search strategy

An electronic search using MEDLINE database was performed. Articles published up to June 30, 2018 were considered. No language or time restrictions were applied in the search. However, only studies written in English were included for selection.

Search terms

The electronic search strategy included terms related to the intervention and used the following combination of key words and MeSH terms: leukocyte platelet-rich fibrin” OR “pure platelet-rich fibrin” OR “LPRF” OR “L-PRF” OR “advanced platelet-rich fibrin” OR “APRF” OR “A-PRF” OR “L-PRF Gel” OR “leukocytes“ OR “platelets” OR “blood platelets” OR “platelet” AND “in vitro techniques” OR “cytokines” OR “intercellular signaling peptides and proteins” OR “intercellular” OR intercellular signaling peptides and proteins” OR “growth factors” OR “transforming growth factor beta” OR “bone marrow” OR “stem cells” OR “macrophages” OR “osteoclasts” OR “inflammation“ OR “Cell Physiological Phenomena” OR “Cell Plasticity” OR “cell differentiation” OR “osseointegration” OR “Dental Implants.”

Criteria for study selection and inclusion

Only in vitro studies evaluating the effect of PRF were considered.

Exclusion criteria

In vitro studies using other kinds of platelet concentrates such as PRGF or PRP or any other platelet concentrate that required the addition of anticoagulant. Pre-clinical and in vitro studies that did not use human blood.

Screening and selection of studies

Publication records and titles identified by the electronic search were independently screened by two reviewers (JN and ZK) based on the inclusion criteria. Discrepancies were solved by discussion among authors (RG and FJS). Cohen’s Kappa-coefficient was used as a measure of agreement between the readers. Thereafter, full texts of the selected abstracts were obtained. The two reviewers independently performed the screening process, i.e., from the MeSH term search up to the full-text examination. Then, articles that met the inclusion criteria were processed for data extraction.

Data extraction and analysis

The inclusion criteria were applied for data extraction. The studies were classified according to study design and type of methods applied. Then, outcomes were compiled in tables. All extracted data were double-checked, and any questions that came up during the screening and the data extraction were discussed within the authors to aim for consensus.

Results

Selection of studies

In the original search 1746 potential references were identified in Medline which 59 were eligible after title and abstract screening (inter-reviewer agreement κ = 0.952). Of the 59 full-text articles, 22 did not meet the inclusion criteria and were excluded (Fig. 1) obtaining 37 studies for data extraction (Table 1). During the submission-process of the present review, 16 new studies meeting the inclusion criteria were published and therefore included for data extraction (Table 2).

Proliferation

PRF increased proliferation of mesenchymal cells, for example from bone of different origin [19, 24–26, 28, 45, 50, 66, ], bone marrow [32, 39], periosteum [27], adipose tissue [37, 47, 68], and skin [65, 48]. Also, fibroblasts from gingiva [38, 44], periodontal ligament [18, 52, 59], papilla [30], and dental pulp responded to PRF with increased proliferation [29, 31, 43, 54]. These observations were reproduced in embryonic kidney fibroblasts and in various cell lines such as HEK293, MG-63 osteosarcoma cells, human oral keratinocytes, SIRC, and 3T3 cells [18]. Mesenchymal cells, endothelial cells [23, 42, 55, 63], epithelial cells [22], and macrophages [69] also responded to PRF with increasing proliferation. In contrast, PRF failed to induce proliferation of L929 fibroblasts [53] and human mesenchymal stem cells on collagen scaffolds [17]. In general, PRF maintained cell viability [33, 63–66, ] without inducing apoptosis [40]. Overall, there is a general consensus that PRF has a potent mitogenic activity.

Migration

There are various methods to identify the impact of PRF on cell migration including the scratch assay [70] and the traditional Boyden chamber approach [71]. Regardless of the method used, PRF increased the migration of neural stem cells [54] along with cells of the mesenchymal lineage isolated from bone [45, 64], bone marrow [72], gingiva [38, 64, 36], apical papilla [30], and skin [65, 48]. Similarly, endothelial cells responded to PRF with an increased migration [63, 72, 41]. In contrast, an inhibitory effect of PRF on cell migration was also observed on bone marrow cells but likely due to the aggregation and proliferation effect of PRF that precedes migration [32]. Likewise, in one recent study, PRF failed to induce migration on L929 fibroblasts [53]. However, the general view is that PRF supports cell motility.

Alkaline phosphatase and alizarin red staining

The main early marker of osteogenic differentiation is alkaline phosphatase [73]. Various studies showed that PRF increases the expression or the activity of alkaline phosphatase in cells of the mesenchymal lineage isolated from bone [45, ], bone marrow [25], apical papilla [30], dental pulp [31, 34, 43, 49], periodontal ligament [59, 74], osteosarcoma cell lines [21], and other tissues [24]. Moreover, PRF increased mineralized nodules in cells from dental pulp [34, 43, 49], calvaria bone [28], bone marrow [32], and periodontal ligament [59]. Conversely, one study showed an inhibitory effect of PRF on alkaline phosphatase activity [52]. In two other reports, PRF failed to change alkaline phosphatase activity and did not change alkaline phosphatase expression in rat calvaria osteoblasts [28] and bone marrow cells [40], respectively. Taken together, all but three studies reported an increase of alkaline phosphatase in response to PRF exposure.

Growth factors and extracellular matrix

PRF caused a moderate expression of various growth factors in mesenchymal and endothelial cells such as TGFβ [38, 46, 52, 56, 65, 36], PDGF [23, 38, 40, 46, 52, 56, 65, 36], and VEGF [23, 37, 58]. Dental pulp cells treated with PRF increased expression of dentin sialoprotein and dentin matrix protein 1 [29, 34, 49]. With respect to changes in the expression of extracellular matrix protein, PRF increased collagen type 1 in mesenchymal cells of the bone [45], skin [65], and gingiva [38, 73]. Likewise, PRF increased the expression of osteopontin, MMP2, and MMP9 in human bone marrow cells [40]. Conversely, PRF reduced the expression of bone sialoprotein and osteocalcin along with a transient downregulation of collagen type 1 in periodontal ligament cells [52]. Similarly, a downregulation of bone sialoprotein, dentin matrix protein 1, and dentin sialoprotein in cells from the papilla was reported [30]. It should be noted, however, that this downregulation disappeared after 14 days of stimulation [30]. In general, the reported increase of gene expression by PRF is moderate.

Cell adhesion

Cell adhesion proteins were enhanced by PRF, for example, ICAM-1 and E-selectin in cocultures of osteogenic and endothelial cells [23] and ICAM-1 in pulp cells [34]. Furthermore, PRF supported adhesion of mesenchymal cells [17], HUVEC [41], U2OS [50], and HBASC [51] on different scaffolds. These positive results nonetheless were not replicated on titanium surfaces [46] and culture plates [45]. Together, these observations suggest that in the majority of experiments, PRF could support cell adhesion.

Cell signaling, inflammation, and osteoclastogenesis

PRF enhanced the phosphorylation of Akt, heat shock protein 47 and lysis oxidase in osteosarcoma cells [50], and VEGFR2 in endothelial cells [35]. PRF enhanced phosphorylation of ERK in osteosarcoma cells [19], and periodontal fibroblasts [74] along with an increase in OPG expression in both cell types. This PRF-induced OPG expression was also reported on dental pulp cells [31]. Moreover, PRF reduced LPS-induced cytokine production in pulp cells and enhanced the up-regulation of odontoblastic differentiation markers DSP and DMP-1 in these cells [34]. Similarly, PRF suppressed the LPS- and saliva-induced pro-inflammatory cytokines on primary and RAW264.7 macrophages and attenuated the translocation of NF-κB into the nucleus [69]. This anti-inflammatory effect was replicated in gingival fibroblasts [61]. In addition, in dental pulp cells, PRF increased DSP and DMP1 expression along with an activation of BMP 2/4 signaling and phosphorylation of SMAD1/5/8 cascade [49]. Osteoclasts originate from hematopoietic progenitors and in the presence of the survival factor (M-CSF) and RANKL differentiate into osteoclasts staining positive for TRAP. PRF suppressed the expression of osteoclast marker genes TRAP, DCSTAMP, NFATc, and OSCAR. Altogether, these results suggest that PRF can affect central signaling pathways, possesses an anti-inflammatory effect, and is capable of inhibiting osteoclastogenesis [57].

Discussion

This systematic review encompassed in vitro studies using PRF and can be viewed as an extension of the previous work of Miron et al. [16]. Our aim was to gather the current in vitro evidence on cellular responses to PRF. Despite the steadily increasing number of in vitro studies, much of the available evidence has focused on confirming similar findings. The majority of studies assessed the impact of PRF on proliferation, adhesion, migration, and differentiation mainly on mesenchymal cells and to some extent, endothelial and epithelial cells. Overall, PRF triggered an increase in the above-mentioned parameters and revealed anti-inflammatory properties. PRF also showed a moderate but consistent capacity to modulate the expression of target genes activating different signaling pathways.

A meta-analysis could not be performed as the included studies revealed heterogeneity in terms of study design, evaluation methods, outcome measures, and observation periods. Besides the original L-PRF protocol, other PRF protocols were used, however, most studies did not provide enough details. These details are of importance as with different protocols [3], i.e., centrifugation time and g-force, characteristics such as the release of growth factors or the content of living cells are substantially changed [75]. For instance, by reducing the g-force, there is an improvement in growth release and cell content. This finding is considered one of the major innovations in PRF leading to the development of new protocols including advanced platelet-rich fibrin (A-PRF+), injectable PRF (i-PRF), and liquid PRF (fluid-PRF). In addition, there are other factors that were not considered in the different preparation protocols such as the centrifugation tubes which have a strong impact on the clot size [76]. Indeed, the silica used to coat plastic tubes might contaminate PRF and thereby provoking inflammation [77]. Likewise, differences in g-forces, blood volume, hematocrit levels, centrifugation time, and handling of PRF membranes impede an accurate comparison between the protocols. Furthermore, PRF lysates, PRF conditioned medium, and PRF exudates should also be distinguished from traditional protocols. Although these issues are at the heart of scientific discussion [78, 79], the main in vitro findings are rather consistent.

Successful tissue regeneration and osseointegration rely on the response of the surrounding cells. These biological processes inevitably require proliferation, migration, and differentiation of cells at the treatment site.

PRF consistently increased cell proliferation irrespective of the cell type and PRF preparation. One interesting setting was the increased cell proliferation on collagen matrices [72] and titanium surfaces [46] upon PRF coating. It is worth noting that two studies found a conspicuously reduced proliferation in gingival fibroblast [44] and dental pulp stem cells [43]. It is difficult, however, to determine why PRF led to a decline in cell proliferation. PRF membranes covering cells might decrease oxygenation [44]. Nonetheless, PRF preparation without providing enough details complicates the interpretation of the data [43]. Despite these shortcomings, the majority of the in vitro studies suggest a mitogenic activity of PRF for various cell types that might be attributed to the strong mitogen PDGF released by activated platelets [13, 80].

Cell migration was positively induced in all but two of the selected studies. This chemotactic effect is likely due to the presence of growth factors contained in platelets such as PDGF [12]. This growth factor, for example, pushes proliferation of osteogenic cells in vitro [81]. In addition, endothelial cells followed a similar pattern of displaying an increase in migration upon exposure to PRF [40]. Although the activation of platelets might account for these observations [11], the precise mechanism remains to be elucidated. In support of the mitogenic and chemotactic activity, PRF enhanced the phosphorylation of Akt [50], and ERK [19, 74] similar to what is observed in isolated platelets [12]. Conversely, inhibition of migration by PRF has been reported in alveolar bone marrow cells [32]. This effect might be explained by the aggregation and proliferation effect of PRF that precedes migration and also by methodological differences, which precludes an interpretation and a comparison with the other studies [3]. Despite these inconsistencies, PRF is able to induce cell migration, likely due to the presence of growth factors such as PDGF with chemotactic activity.

Cell differentiation is commonly assessed by means of measuring alkaline phosphatase and alizarin red staining. Various studies showed that PRF increases the expression or the activity of alkaline phosphatase in cells of the mesenchymal lineage [24, 25, 29–31, 34, 43, 45, 49, 65, 59, 74]. Some data, nonetheless, are conflicting since PRF can also reduce alkaline phosphatase activity [52] consistent with the effects of supernatants of isolated platelets [12]. This reduction may be attributed to TGF-β [82] and PDGF [12]. On the other hand, the increased mineralized nodules elicited by PRF in cells from dental pulp [34, 43, 49], calvaria bone [28], bone marrow [32], and periodontal ligament [59] appear to be a consequence of the enhanced proliferation, alkaline phosphatase activity, and production of collagen matrix. These in vitro findings, however, have to be interpreted with caution as proliferation and differentiation do not occur simultaneously [73].

With respect to growth factors such as TGFβ, PDGF, and VEGF, PRF moderately increased their expression. Regarding extracellular matrix proteins, PRF moderately increased the expression of collagen type 1, which is a known TGFβ target gene [83, 84] in mesenchymal cells of various origins. In line with collagen type 1 synthesis, PRF activates the expression of HSP47 and lysine oxidase [50]. Cell adhesion proteins were enhanced by PRF [23], however, they are not necessarily responsible for the increased cell adhesion on different scaffolds [51]. Together, these observations suggest that PRF induces moderate changes in gene expression. In contrast, recent data at our lab indicate a robust activation of TGFβ target genes IL11, PRG4, and NOX4 by PRF lysates (Di Summa et al. unpublished observation). TGF-β couples osteogenesis with angiogenesis by providing a pro-osteogenic microenvironment in vivo [62]. As TGF-β induces pro-osteogenic factors and TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in vivo [62], PRF-derived TGF-β may support bone regeneration.

This systematic review revealed an anti-inflammatory effect of PRF. Moreover, during the submission process of the present review, new studies were published highlighting these anti-inflammatory effects of PRF. For example, PRF reduced the LPS-induced proinflammatory cytokine release in gingival fibroblasts [61]. In addition, we have recently shown that PRF reduces the expression of the M1 marker genes interleukin 1β (IL1β) and interleukin 6 (IL6) in bone marrow macrophages [69]. This anti-inflammatory effect might be explained by the high amounts of TGFβ in PRF [73] capable of modulating the M1 and M2 polarization along with the generation of pro-resolving lipid mediators [69]. Additionally, PRF induces the expression of the M2 markers arginase-1 and chitinase-like 3 (Chil3 or YM1) thereby assisting a M1-to-M2 transition [69]. Since dental implants activate the immune system during the early stages of osseointegration [85], the addition of PRF may support a M2 polarization reducing the time lag for osseointegration and bone regeneration. Notably, PRF can also decrease the formation of osteoclast-like cell in a murine bone marrow culture [57]. Similar findings were also reported in peripheral blood mononuclear cells derived CD14⁺ cells [86]. These observations are of particular interest since the favorable effects of PRF in alveolar ridge preservation [6] might be partly explained by an inhibition of osteoclastogenesis. Thus, accumulating evidence suggest that PRF possesses an anti-inflammatory activity and is capable of suppressing osteoclastogenesis.

PRF is a potent inducer of the in vitro angiogenic process indicated by endothelial proliferation, migration, and tube formation. PRF supports microvessel-like structures [23, 56] and induces blood vessel formation in the chorioallantoic membrane assay [63]. Apart from in vitro angiogenesis, a recent report described an antimicrobial effect of PRF. In that study, both PRF membranes and PRF exudates had an antimicrobial effect against P. gingivalis, a key periodontal pathogen [87]. Those findings support the rationale of using PRF as an adjunctive therapy for peri-implantitis [88]. These observations are also in line with previous data on purified activated platelet showing an angiogenic [11] and antimicrobial effect [89]. Overall, these findings imply that PRF possesses angiogenic and antimicrobial properties.

We recognize that the present report has a number of limitations. PRF is widely used in regenerative dentistry, however, in vitro models represent only a narrow aspect of wound healing and bone regeneration neglecting the holistic nature of an in vivo model. Furthermore, and considering that wound healing and bone regeneration involve granulocytes, lymphocytes and other cell types, today’s PRF research only covers a restricted spectrum of cells. It should also be noted that the same stimuli may play different roles depending on the differentiation stage of the target cell. For example, our group demonstrated that PRF membranes inhibit the formation of osteoclasts in bone marrow cultures [57]. This inhibition, however, did not occur when osteoclastogenesis had already started [57].

Future studies should, for example, include research on the immigration and activation of granulocytes and how PRF might control the resolution of inflammation. Moreover, and considering the importance of centrifugation tubes and the possible impact of silica coating, more studies investigating this issue are needed for the optimization of PRF. Finally, the overall question of whether the in vitro PRF research reflects the clinical reality serving as a surrogate parameter to adapt the current PRF protocols remains to be clarified.

Conclusion

Despite some notable differences of the included studies, the overall findings suggest a benefit of PRF on cell proliferation, migration, adhesion, differentiation, and inflammation pointing towards a therapeutic potential in wound healing and regeneration.

Competing interests

Conflict of interestAll authors declare that they have no conflict of interest.

References

1. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 doi:10.1016/j.tripleo.2005.07.008 PubMed
2. Miron RJ, Chai J, Zheng S, Feng M, Sculean A, Zhang Y. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. J Biomed Mater Res A. 2019 doi:10.1002/jbm.a.36734 PubMed
3. Miron Richard J., Pinto Nelson R., Quirynen Marc, Ghanaati Shahram. Standardization of relative centrifugal forces in studies related to platelet‐rich fibrin. Journal of Periodontology. 2019 doi:10.1002/JPER.18-0553 PubMed
4. Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W et al. Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J Clin Periodontol. 2017 doi:10.1111/jcpe.12643 PubMed
5. Strauss FJ, Stahli A, Gruber R. The use of platelet-rich fibrin to enhance the outcomes of implant therapy: a systematic review. Clin Oral Implants Res. 2018 doi:10.1111/clr.13275 PubMed
6. Temmerman A, Vandessel J, Castro A, Jacobs R, Teughels W, Pinto N et al. The use of leucocyte and platelet-rich fibrin in socket management and ridge preservation: a split-mouth, randomized, controlled clinical trial. J Clin Periodontol. 2016 doi:10.1111/jcpe.12612 PubMed
7. Öncü E, Alaaddinoglu EE. The effect of platelet-rich fibrin on implant stability. The International Journal of Oral & Maxillofacial Implants. 2015 doi:10.11607/jomi.3897 PubMed
8. Tabrizi R., Arabion H., Karagah T.. Does platelet-rich fibrin increase the stability of implants in the posterior of the maxilla? A split-mouth randomized clinical trial. International Journal of Oral and Maxillofacial Surgery. 2018 doi:10.1016/j.ijom.2017.07.025 PubMed
9. Temmerman A, Cleeren GJ, Castro AB, Teughels W, Quirynen M. L-PRF for increasing the width of keratinized mucosa around implants: a split-mouth, randomized, controlled pilot clinical trial. J Periodontal Res. 2018 doi:10.1111/jre.12568 PubMed
10. Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev. 2010 doi:10.1089/ten.TEB.2009.0687 PubMed
11. Kandler B, Fischer MB, Watzek G, Gruber R. Platelet-released supernatant increases matrix metalloproteinase-2 production, migration, proliferation, and tube formation of human umbilical vascular endothelial cells. J Periodontol. 2004 doi:10.1902/jop.2004.75.9.1255 PubMed
12. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets. 2004 doi:10.1080/09537100310001643999 PubMed
13. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res. 2002 doi:10.1034/j.1600-0501.2002.130513.x PubMed
14. Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg (Br). 2009 doi:10.1302/0301-620X.91B8.22546 PubMed
15. Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev. 2008 doi:10.1089/ten.teb.2008.0062 PubMed
16. Miron RJ, Fujioka-Kobayashi M, Bishara M, Zhang Y, Hernandez M, Choukroun J. Platelet-rich fibrin and soft tissue wound healing: a systematic review. Tissue Eng Part B Rev. 2017 doi:10.1089/ten.TEB.2016.0233 PubMed
17. Beitzel K, McCarthy MB, Cote MP, Russell RP, Apostolakos J, Ramos DM et al. Properties of biologic scaffolds and their response to mesenchymal stem cells. Arthroscopy. 2014 doi:10.1016/j.arthro.2013.11.020 PubMed
18. Burnouf T, Lee CY, Luo CW, Kuo YP, Chou ML, Wu YW et al. Human blood-derived fibrin releasates: composition and use for the culture of cell lines and human primary cells. Biologicals. 2012 doi:10.1016/j.biologicals.2011.09.017 PubMed
19. Chang IC, Tsai CH, Chang YC. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A. 2010 doi:10.1002/jbm.a.32839 PubMed
20. Chang Y-C, Zhao J-H. Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. Australian Dental Journal. 2011 doi:10.1111/j.1834-7819.2011.01362.x PubMed
21. Clipet F, Tricot S, Alno N, Massot M, Solhi H, Cathelineau G et al. In vitro effects of Choukroun's platelet-rich fibrin conditioned medium on 3 different cell lines implicated in dental implantology. Implant Dent. 2012 doi:10.1097/ID.0b013e31822b9cb4 PubMed
22. Dereli Can G, Akdere OE, Can ME, Aydin B, Cagil N, Gumusderelioglu M. A completely human-derived biomaterial mimicking limbal niche: platelet-rich fibrin gel. Exp Eye Res. 2018 doi:10.1016/j.exer.2018.04.013 PubMed
23. Dohle E, El Bagdadi K, Sader R, Choukroun J, James Kirkpatrick C, Ghanaati S. Platelet-rich fibrin-based matrices to improve angiogenesis in an in vitro co-culture model for bone tissue engineering. J Tissue Eng Regen Med. 2018 doi:10.1002/term.2475 PubMed
24. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 doi:10.1016/j.tripleo.2009.04.020 PubMed
25. Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol. 2010 doi:10.1016/j.archoralbio.2010.01.004 PubMed
26. Gassling V, Hedderich J, Acil Y, Purcz N, Wiltfang J, Douglas T. Comparison of platelet rich fibrin and collagen as osteoblast-seeded scaffolds for bone tissue engineering applications. Clin Oral Implants Res. 2013 doi:10.1111/j.1600-0501.2011.02333.x PubMed
27. Gassling V, Douglas T, Warnke PH, Acil Y, Wiltfang J, Becker ST. Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clin Oral Implants Res. 2010 doi:10.1111/j.1600-0501.2009.01900.x PubMed
28. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 doi:10.1016/j.tripleo.2009.06.044 PubMed
29. He X, Chen WX, Ban G, Wei W, Zhou J, Chen WJ et al. A new method to develop human dental pulp cells and platelet-rich fibrin complex. J Endod. 2016 doi:10.1016/j.joen.2016.08.011 PubMed
30. Hong S, Chen W, Jiang B. A comparative evaluation of concentrated growth factor and platelet-rich fibrin on the proliferation, migration, and differentiation of human stem cells of the apical papilla. J Endod. 2018 doi:10.1016/j.joen.2018.03.006 PubMed
31. Huang FM, Yang SF, Zhao JH, Chang YC. Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. J Endod. 2010 doi:10.1016/j.joen.2010.07.004 PubMed
32. Kang YH, Jeon SH, Park JY, Chung JH, Choung YH, Choung HW et al. Platelet-rich fibrin is a bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng Part A. 2011 doi:10.1089/ten.TEA.2010.0327 PubMed
33. Khurana R, Kudva PB, Husain SY. Comparative evaluation of the isolation and quantification of stem cells derived from dental pulp and periodontal ligament of a permanent tooth and to assess their viability and proliferation on a platelet-rich fibrin scaffold. J Indian Soc Periodontol. 2017 doi:10.4103/jisp.jisp_182_16 PubMed
34. Kim JH, Woo SM, Choi NK, Kim WJ, Kim SM, Jung JY. Effect of platelet-rich fibrin on odontoblastic differentiation in human dental pulp cells exposed to lipopolysaccharide. J Endod. 2017 doi:10.1016/j.joen.2016.11.002 PubMed
35. Kobayashi M, Kawase T, Okuda K, Wolff LF, Yoshie H. In vitro immunological and biological evaluations of the angiogenic potential of platelet-rich fibrin preparations: a standardized comparison with PRP preparations. Int J Implant Dent. 2015 doi:10.1186/s40729-015-0032-0 PubMed
36. Schar MO, Diaz-Romero J, Kohl S, Zumstein MA, Nesic D. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro. Clin Orthop Relat Res. 2015 doi:10.1007/s11999-015-4192-2 PubMed
37. Liang ZJ, Lu X, Li DQ, Liang YD, Zhu DD, Wu FX et al. Precise intradermal injection of nanofat-derived stromal cells combined with platelet-rich fibrin improves the efficacy of facial skin rejuvenation. Cell Physiol Biochem. 2018 doi:10.1159/000489809 PubMed
38. Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?. Clin Oral Investig. 2017 doi:10.1007/s00784-017-2063-9 PubMed
39. Kim J, Ha Y, Kang NH. Effects of growth factors from platelet-rich fibrin on the bone regeneration. J Craniofac Surg. 2017 doi:10.1097/SCS.0000000000003396 PubMed
40. Verboket R, Herrera-Vizcaino C, Thorwart K, Booms P, Bellen M, Al-Maawi S et al. Influence of concentration and preparation of platelet rich fibrin on human bone marrow mononuclear cells (in vitro). Platelets. 2019 doi:10.1080/09537104.2018.1530346 PubMed
41. Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. Optimized platelet-rich fibrin with the low-speed concept: growth factor release, biocompatibility, and cellular response. J Periodontol. 2017 doi:10.1902/jop.2016.160443 PubMed
42. Passaretti F, Tia M, D'Esposito V, De Pascale M, Del Corso M, Sepulveres R et al. Growth-promoting action and growth factor release by different platelet derivatives. Platelets. 2014 doi:10.3109/09537104.2013.809060 PubMed
43. Saeed MA, El-Rahman MA, Helal ME, Zaher AR, Grawish ME. Efficacy of human platelet rich fibrin exudate vs fetal bovine serum on proliferation and differentiation of dental pulp stem cells. Int J Stem Cells. 2017 doi:10.15283/ijsc16067 PubMed
44. Vahabi S, Vaziri S, Torshabi M, Rezaei Esfahrood Z. Effects of plasma rich in growth factors and platelet-rich fibrin on proliferation and viability of human gingival fibroblasts. J Dent (Tehran). 2015 PubMed
45. Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018 doi:10.1080/09537104.2017.1293807 PubMed
46. Wang Xuzhu, Zhang Yufeng, Choukroun Joseph, Ghanaati Shahram, Miron Richard. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. International Journal of Molecular Sciences. 2017 doi:10.3390/ijms18020331 PubMed
47. Wei H, Gu SX, Liang YD, Liang ZJ, Chen H, Zhu MG et al. Nanofat-derived stem cells with platelet-rich fibrin improve facial contour remodeling and skin rejuvenation after autologous structural fat transplantation. Oncotarget. 2017 doi:10.18632/oncotarget.19721 PubMed
48. Wirohadidjojo YW, Budiyanto A, Soebono H. Platelet-rich fibrin lysate can ameliorate dysfunction of chronically UVA-irradiated human dermal fibroblasts. Yonsei Med J. 2016 doi:10.3349/ymj.2016.57.5.1282 PubMed
49. Woo SM, Kim WJ, Lim HS, Choi NK, Kim SH, Kim SM et al. Combination of mineral trioxide aggregate and platelet-rich fibrin promotes the odontoblastic differentiation and mineralization of human dental pulp cells via BMP/Smad signaling pathway. J Endod. 2016 doi:10.1016/j.joen.2015.06.019 PubMed
50. Wu CL, Lee SS, Tsai CH, Lu KH, Zhao JH, Chang YC. Platelet-rich fibrin increases cell attachment, proliferation and collagen-related protein expression of human osteoblasts. Aust Dent J. 2012 doi:10.1111/j.1834-7819.2012.01686.x PubMed
51. Xu FT, Liang ZJ, Li HM, Peng QL, Huang MH, Li de Q et al. Ginsenoside Rg1 and platelet-rich fibrin enhance human breast adipose-derived stem cell function for soft tissue regeneration. Oncotarget. 2016 doi:10.18632/oncotarget.9360 PubMed
52. Zhao YH, Zhang M, Liu NX, Lv X, Zhang J, Chen FM et al. The combined use of cell sheet fragments of periodontal ligament stem cells and platelet-rich fibrin granules for avulsed tooth reimplantation. Biomaterials. 2013 doi:10.1016/j.biomaterials.2013.03.079 PubMed
53. Bucur M, Constantin C, Neagu M, Zurac S, Dinca O, Vladan C et al. Alveolar blood clots and platelet-rich fibrin induce in vitro fibroblast proliferation and migration. Exp Ther Med. 2019 doi:10.3892/etm.2018.7063 PubMed
54. Gervois P, Ratajczak J, Wolfs E, Vangansewinkel T, Dillen Y, Merckx G et al. Preconditioning of human dental pulp stem cells with leukocyte- and platelet-rich fibrin-derived factors does not enhance their neuroregenerative effect. Stem Cells Int. 2019 doi:10.1155/2019/8589149 PubMed
55. Gomez TW, Gopal RV, Gaffoor FMA, Kumar STR, Girish CS, Prakash R. Comparative evaluation of angiogenesis using a novel platelet-rich product: an in vitro study. J Conserv Dent. 2019 doi:10.4103/JCD.JCD_216_18 PubMed
56. Herrera-Vizcaino C, Dohle E, Al-Maawi S, Booms P, Sader R, Kirkpatrick CJ et al. Platelet-rich fibrin secretome induces three dimensional angiogenic activation in vitro. Eur Cell Mater. 2019 doi:10.22203/eCM.v037a15 PubMed
57. Kargarpour Z, Nasirzade J, Strauss FJ, Di Summa F, Hasannia S, Muller HD, Gruber R (2019) Platelet-rich fibrin suppresses in vitro osteoclastogenesis. J Periodontol. 10.1002/JPER.19-010910.1002/JPER.19-0109PMC715512631381154 doi:10.1002/JPER.19-0109 PubMed
58. Kasnak G, Fteita D, Jaatinen O, Kononen E, Tunali M, Gursoy M et al. Regulatory effects of PRF and titanium surfaces on cellular adhesion, spread, and cytokine expressions of gingival keratinocytes. Histochem Cell Biol. 2019 doi:10.1007/s00418-019-01774-8 PubMed
59. Li X, Yang H, Zhang Z, Yan Z, Lv H, Zhang Y et al. Plateletrich fibrin exudate promotes the proliferation and osteogenic differentiation of human periodontal ligament cells in vitro. Mol Med Rep. 2018 doi:10.3892/mmr.2018.9472 PubMed
60. Mahendran K, Kottuppallil G, Sekar V (2019) Comparative evaluation of radiopacity and cytotoxicity of platelet-rich fibrin, platelet-rich fibrin + 50wt% nano-hydroxyapatite, platelet-rich fibrin + 50wt% dentin chips: An in vitro study. J Conserv Dent 22 (1):28-33. 10.4103/JCD.JCD_281_1810.4103/JCD.JCD_281_18PMC638556630820079 doi:10.4103/JCD.JCD_281_18 PubMed
61. Mudalal M, Sun X, Li X, Zhou Y. The evaluation of leukocyte-platelet rich fibrin as an anti-inflammatory autologous biological additive. A novel in vitro study. Saudi Med J. 2019 doi:10.15537/smj.2019.7.24302 PubMed
62. Qin Y, Tang S, Zhen G, Ding Q, Ding S, Cao X. Bone-targeted delivery of TGF-beta type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease. Ann N Y Acad Sci. 2018 doi:10.1111/nyas.13941 PubMed
63. Ratajczak J, Vangansewinkel T, Gervois P, Merckx G, Hilkens P, Quirynen M et al. Angiogenic properties of ‘leukocyte- and platelet-rich Fibrin’. Sci Rep. 2018 doi:10.1038/s41598-018-32936-8 PubMed
64. Steller D, Herbst N, Pries R, Juhl D, Hakim SG. Positive impact of platelet-rich plasma and platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid. Sci Rep. 2019 doi:10.1038/s41598-019-43798-z PubMed
65. Wang Xuzhu, Yang Yang, Zhang Yufeng, Miron Richard J.. Fluid platelet‐rich fibrin stimulates greater dermal skin fibroblast cell migration, proliferation, and collagen synthesis when compared to platelet‐rich plasma. Journal of Cosmetic Dermatology. 2019 doi:10.1111/jocd.12955 PubMed
66. Steller Daniel, Herbst Nele, Pries Ralph, Juhl David, Klinger Matthias, Hakim Samer G.. Impacts of platelet‐rich fibrin and platelet‐rich plasma on primary osteoblast adhesion onto titanium implants in a bisphosphonate in vitro model. Journal of Oral Pathology & Medicine. 2019 doi:10.1111/jop.12944 PubMed
67. Moradian H, Rafiee A, Ayatollahi M. Design and fabrication of a novel transplant combined with human bone marrow mesenchymal stem cells and platelet-rich fibrin: new horizons for periodontal tissue regeneration after dental trauma. Iran J Pharm Res. 2017 PubMed
68. Elgamal A, Althani AA, Abd-Elmaksoud A, Kassab M, Farag A, Lashen S et al. Xeno-free trans-differentiation of adipose tissue-derived mesenchymal stem cells into glial and neuronal cells. Am J Stem Cells. 2019 PubMed
69. Nasirzade J, Kargarpour Z, Hasannia S, Strauss FJ, Gruber R (2019) Platelet-rich fibrin elicits an anti-inflammatory response in macrophages in vitro. J Periodontol. 10.1002/JPER.19-021610.1002/JPER.19-0216PMC706513631376159 doi:10.1002/JPER.19-0216 PubMed
70. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007 doi:10.1038/nprot.2007.30 PubMed
71. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 doi:10.1084/jem.115.3.453 PubMed
72. Park JS, Pabst AM, Ackermann M, Moergel M, Jung J, Kasaj A. Biofunctionalization of porcine-derived collagen matrix using enamel matrix derivative and platelet-rich fibrin: influence on mature endothelial cell characteristics in vitro. Clin Oral Investig. 2018 doi:10.1007/s00784-017-2170-7 PubMed
73. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev. 1993 doi:10.1210/edrv-14-4-424 PubMed
74. Chang YC, Zhao JH. Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. Aust Dent J. 2011 doi:10.1111/j.1834-7819.2011.01362.x PubMed
75. Kobayashi E, Fluckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016 doi:10.1007/s00784-016-1719-1 PubMed
76. Miron RJ, Xu H, Chai J, Wang J, Zheng S, Feng M, Zhang X, Wei Y, Chen Y, Mourao C, Sculean A, Zhang Y (2019) Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces. Clin Oral Investig. 10.1007/s00784-019-02981-210.1007/s00784-019-02981-231321574 doi:10.1007/s00784-019-02981-2 PubMed
77. Tsujino Tetsuhiro, Takahashi Akira, Yamaguchi Sadahiro, Watanabe Taisuke, Isobe Kazushige, Kitamura Yutaka et al. Evidence for Contamination of Silica Microparticles in Advanced Platelet-Rich Fibrin Matrices Prepared Using Silica-Coated Plastic Tubes. Biomedicines. 2019 doi:10.3390/biomedicines7020045 PubMed
78. Miron R, Choukroun J., Ghanaati, S. (2018) Controversies related to scientific report describing g-forces from studies on platelet-rich fibrin: necessity for standardization of relative centrifugal force values. International Journal of Growth Factors and Stem Cell in Dentistry
79. Pinto Nelson, Quirynen Marc. Letter to the editor: RE: Optimized platelet-rich fibrin with the low-speed concept: Growth factor release, biocompatibility, and cellular response. Journal of Periodontology. 2018 doi:10.1002/JPER.18-0175 PubMed
80. Antoniades HN, Scher CD, Stiles CD. Purification of human platelet-derived growth factor. Proc Natl Acad Sci U S A. 1979 doi:10.1073/pnas.76.4.1809 PubMed
81. Tsukamoto T, Matsui T, Fukase M, Fujita T. Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun. 1991 doi:10.1016/0006-291x(91)91629-q PubMed
82. Noda M, Rodan GA. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun. 1986 doi:10.1016/0006-291x(86)91057-0 PubMed
83. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem. 1994 PubMed
84. Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroenterol. 2007 doi:10.3748/wjg.v13.i22.3056 PubMed
85. Trindade R, Albrektsson T, Galli S, Prgomet Z, Tengvall P, Wennerberg A. Osseointegration and foreign body reaction: titanium implants activate the immune system and suppress bone resorption during the first 4 weeks after implantation. Clin Implant Dent Relat Res. 2018 doi:10.1111/cid.12578 PubMed
86. Kumar A, Mahendra J, Samuel S, Govindraj J, Loganathan T, Vashum Y et al. Platelet-rich fibrin/biphasic calcium phosphate impairs osteoclast differentiation and promotes apoptosis by the intrinsic mitochondrial pathway in chronic periodontitis. J Periodontol. 2019 doi:10.1002/JPER.17-0306 PubMed
87. Castro AB, Herrero ER, Slomka V, Pinto N, Teughels W, Quirynen M. Antimicrobial capacity of leucocyte-and platelet rich fibrin against periodontal pathogens. Sci Rep. 2019 doi:10.1038/s41598-019-44755-6 PubMed
88. Hamzacebi B, Oduncuoglu B, Alaaddinoglu EE. Treatment of Peri-implant bone defects with platelet-rich fibrin. Int J Periodontics Restorative Dent. 2015 doi:10.11607/prd.1861 PubMed
89. Xu J, Yi J, Zhang H, Feng F, Gu S, Weng L et al. Platelets directly regulate DNA damage and division of Staphylococcus aureus. FASEB J. 2018 doi:10.1096/fj.201701190R PubMed